论文部分内容阅读
［目的］评估布克勒（Ｂｕｃｈｌｅｒ）１３７Ｃｓ后装腔内放疗机治疗Ⅱ、Ⅲ期宫颈癌的远期疗效。［方法］总结１９８６年１０月至 １９８７年 １２月间应用“Ｂｕｃｈｌｅｒ”后装机合并６０ＣＯ或８ＭｅＶ直线加速器对Ⅱ、 Ⅲ期的宫颈癌 １４０例进行根治性放射治疗。放疗剂量：腔内放疗Ⅱ期Ａ点６０Ｇｙ～７２Ｇｙ，阴道与宫腔剂量比为４：３或１：１，随后外照射Ｂ点则采用盆腔四野照射，剂量４４Ｇｙ～５６Ｇｙ。Ⅲ期先采用盆腔全盆大野外照射Ｂ点２０Ｇｙ～２９Ｇｙ，随后盆腔四野外照射，Ｂ点补至４５６ｙ～５５Ｇｙ。盆腔四野照射期间配合腔内放疗Ａ点５０Ｇｙ～６０Ｇｙ，阴道与宫腔剂量比为３：２或１：１。［结果］全组患者随访１０年，其中７人失访，随访率为９５％（１３３／１４０）。Ⅱ、 Ⅲ期宫颈癌的１０年生存率分别为５９％（３６／６１）、３１．６４％（２５／７９），总的１０年生存率为４３．５７％（６１／１４０）。［结论］布克勒后装腔内治疗机对宫颈癌的远期疗效比国内报道低，治疗合并症放射性直肠炎、膀胱炎、阴道炎均较高。
[Objective] To evaluate the long-term curative effect of Buchler 137Cs intraocular irradiation machine for treatment of stage II and III cervical cancer. [Methods] From October 1986 to December 1987, 140 patients with stage II and III cervical cancer were treated with “Buchler” combined with 60CO or 8MeV linear accelerator for radical radiotherapy. Radiotherapy dose: endovascular radiotherapy Ⅱ point A point 60Gy ~ 72Gy, vaginal and uterine cavity dose ratio of 4: 3 or 1: 1, followed by external irradiation B point is the use of pelvic four field irradiation dose 44Gy ~ 56Gy. Stage Ⅲ first pelvic basin using the B field point B 20Gy ~ 29Gy, followed by pelvic four field irradiation, B point to 456y ~ 55Gy. Fourteen during pelvic irradiation with intracavitary radiation point A 50Gy ~ 60Gy, vaginal and uterine dose ratio of 3: 2 or 1: 1. [Results] All the patients were followed up for 10 years, of which 7 were lost to follow-up, with a follow-up rate of 95% (133/140). The 10-year survival rates of stage II and stage III cervical cancer were 59% (36/61) and 31.64% (25/79), respectively. The overall 10-year survival rate was 43.57% (61/140). [Conclusion] The long-term curative effect of Buchler posterior endovascular therapy machine on cervical cancer is lower than that reported in China, and radiotherapy proctitis, cystitis and vaginitis are high in the treatment of complications.